(Q41459229)

1 October 2017

1 reference

title

Hodgkin's disease: a tumor with disturbed immunological pathways (English)

1 reference

1 October 2017

1 reference

Gruss HJ

1

1 reference

1 October 2017

Pinto A

2

1 reference

1 October 2017

Duyster J

3

1 reference

1 October 2017

Poppema S

4

1 reference

1 October 2017

Herrmann F

5

1 reference

1 October 2017

publication date

1 April 1997

1 reference

1 October 2017

1 reference

1 October 2017

volume

18

1 reference

1 October 2017

issue

4

1 reference

1 October 2017

page(s)

156-163

1 reference

Pathology of Hodgkin's disease.

1 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984661-0

7 January 2021

Hodgkin's disease with monoclonal and polyclonal populations of Reed-Sternberg cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984661-0

7 January 2021

Expression of T-cell-receptor beta chain in Reed-Sternberg cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984661-0

7 January 2021

Morphologic, immunologic, enzymehistochemical and chromosomal analysis of a cell line derived from Hodgkin's disease. Evidence for a B-cell origin of Sternberg-Reed cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984661-0

7 January 2021

Nodular lymphocyte predominance Hodgkin's disease. A distinct clinicopathological entity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984661-0

7 January 2021

Detection of immunoglobulin heavy-chain gene rearrangement at the single-cell level in malignant lymphomas: no rearrangement is found in Hodgkin and Reed-Sternberg cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984661-0

7 January 2021

Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984661-0

7 January 2021

Phenotype, genotype and clonality of Reed-Sternberg cells in nodular sclerosis Hodgkin's disease: results of a single-cell study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984661-0

7 January 2021

Chromosomal abnormalities in patients with Hodgkin's disease: evidence for frequent involvement of the 14q chromosomal region but infrequent bcl-2 gene rearrangement in Reed-Sternberg cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984661-0

7 January 2021

Epstein-Barr virus and carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984661-0

7 January 2021

Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984661-0

7 January 2021

Decreased expression of cellular markers in Epstein-Barr virus-positive Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984661-0

7 January 2021

The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984661-0

7 January 2021

Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984661-0

7 January 2021

The antigen-presenting cell function of Reed-Sternberg cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984661-0

7 January 2021

Recombinant CD30 ligand and CD40 ligand share common biological activities on Hodgkin and Reed-Sternberg cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984661-0

7 January 2021

Rosetting and other reactions of the Reed-Sternberg cell

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984661-0

7 January 2021

Pathophysiology of Hodgkin's disease: functional and molecular aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984661-0

7 January 2021

Proliferating cell nuclear antigen (PCNA) expression in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984661-0

7 January 2021

CD26/dipeptidyl peptidase IV expression in human lymphomas is restricted to CD30-positive anaplastic large cell and a subset of T-cell non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984661-0

7 January 2021

CD26: a surface protease involved in T-cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984661-0

7 January 2021

Human CD4 helper T cell activation: functional involvement of two distinct collagen receptors, 1F7 and VLA integrin family

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984661-0

7 January 2021

Clonal analysis of T lymphocytes in spleens from patients with Hodgkin's disease. Frequent occurrence of unusual T4-positive cells which co-express cytolytic activity and production of interleukin-2

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984661-0

7 January 2021

The expanding universe of T-cell subsets: Th1, Th2 and more.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984661-0

7 January 2021

CD30 ligand, a member of the TNF ligand superfamily, with growth and activation control CD30+ lymphoid and lymphoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984661-0

7 January 2021

Ki-1 (CD30) antigen is released by Ki-1-positive tumor cells in vitro and in vivo. I. Partial characterization of soluble Ki-1 antigen and detection of the antigen in cell culture supernatants and in serum by an enzyme-linked immunosorbent assay

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984661-0

7 January 2021

CD30, Th2 cytokines and HIV infection: a complex and fascinating link

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984661-0

7 January 2021

Serum levels of soluble CD30 are elevated in the majority of untreated patients with Hodgkin's disease and correlate with clinical features and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984661-0

7 January 2021

High serum level of the soluble form of CD30 molecule in the early phase of HIV-1 infection as an independent predictor of progression to AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984661-0

7 January 2021

The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984661-0

7 January 2021

IgE, Reed-Sternberg cells, and eosinophilia in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2897%2984661-0

7 January 2021

Retracted: Tumor necrosis factor receptor-associated factor (TRAF)-1, TRAF-2, and TRAF-3 interact in vivo with the CD30 cytoplasmic domain; TRAF-2 mediates CD30-induced nuclear factor kappa B activation

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1073/PNAS.93.24.14053

Identifiers

DOI

10.1016/S0167-5699(97)84661-0

1 reference

1 October 2017

1 reference